Nexium generic delayed till 2014
- Share via
From Times Wire Services
A lawsuit settlement between AstraZeneca and India’s Ranbaxy Laboratories will ensure that a cheap, copycat version of the best-selling heartburn drug Nexium won’t hit the market until 2014.
Nexium is the second-biggest prescription medicine globally, with sales of $5.2 billion in 2007. But its future has been under a cloud with the recent expiration of a stay blocking regulatory approval of a generic version.
Under the deal, Ranbaxy can start selling a generic version of Nexium in May 2014.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
